Indeed, treatment with DNMTi and Enhancer of zeste homolog 2 (EZH2) inhibitor was shown to upregulate NKG2D ligand expression, resulting in the lysis of glioma and HCC cells by NK cells, respectively. Here, KLRK1 is linked to glioma.